Manufacturing engineers are at the forefront of bringing new medicines derived from human sources such as cells, blood and genes to patients, Mayo Clinic has said.
Saudi Arabia's Crown Prince His Royal Highness Prince Mohammed bin Salman bin Abdulaziz Al Saud today announced the launch of HUMAIN, a company that will operate and invest across the artificial intelligence (AI) value chain.
Aster DM Healthcare, one of the leading healthcare providers in the GCC, has announced that five of its hospitals have been recognised in Newsweek's prestigious World’s Best Hospitals 2025 list.
Ebn Sina Medical, a subsidiary of Aamal Company and a leading supplier of pharmaceutical, and Novo Nordisk, the Danish global healthcare company, have announced the availability of Wegovy (Semaglutide 2.4mg) in Qatar.
PureHealth Holding, a leading healthcare group in the Middle East, reported a revenue increase of 8% year-on-year to AED6.6 billion ($1.8 billion) driven by growth across all of PureHealth’s segments.
Novo Nordisk, a leading global healthcare company, has signed a deal with Lifera, a biopharma company owned by the Saudi sovereign wealth fund PIF, to pursue the localisation of the manufacturing of semaglutide GLP-1 treatments in the kingdom.
Red Sea Global has announced the launch of its new brand, Botanica - the new name for The Red Sea Landscape Nursery. The largest of its kind in the region at over 1.8 million sq m, Botanica is now open to the public.
UAE telecom company e& said its digital transformation unit has forged a strategic partnership with top telemedicine solutions provider LifeBot to deliver industry grade virtual care services in demanding environments and critical sectors across UAE.
The World Green Economy Organisation will organise the 11th World Green Economy Summit (WGES) on October 1 and 2 at the Dubai World Trade Centre.
Eli Lilly and Company has announced positive topline Phase 3 results from Achieve-1, evaluating the safety and efficacy of orforglipron compared to placebo in adults with type 2 diabetes and inadequate glycemic control with diet and exercise alone.
